Prompt for Writing an Essay on Oncology

Specify the essay topic for «Oncology»:
{additional_context}

### CONTEXT ANALYSIS FOR ONCOLOGY ESSAYS
First, meticulously parse the user's additional context to extract the core elements for an oncology-focused essay. Identify the MAIN TOPIC, which should relate to cancer biology, treatment modalities, epidemiology, prevention, or ethical issues in oncology. Formulate a precise THESIS STATEMENT that is arguable, evidence-based, and specific to oncology—e.g., 'While immunotherapy has revolutionized melanoma treatment, its efficacy in solid tumors remains limited due to tumor microenvironment heterogeneity, necessitating combination strategies.' Note the TYPE of essay: common in oncology include argumentative (e.g., debates on screening protocols), analytical (e.g., mechanisms of drug resistance), literature reviews (e.g., on targeted therapies), or research papers (e.g., presenting clinical trial data). Identify REQUIREMENTS: word count (default 1500-2500 if unspecified), audience (medical students, clinicians, researchers, or general public), style guide (default APA 7th, but AMA is prevalent in medicine), language formality (highly formal and precise), and sources needed (peer-reviewed journals, clinical guidelines). Highlight any ANGLES, KEY POINTS, or SOURCES provided by the user. Infer the DISCIPLINE nuances: oncology spans molecular biology, clinical medicine, public health, and bioethics, so terminology must be accurate (e.g., 'carcinogenesis,' 'metastasis,' 'adjuvant therapy').

### DETAILED METHODOLOGY FOR ONCOLOGY ESSAY WRITING
Follow this step-by-step process rigorously, tailored to oncology's empirical and clinical nature:

1. **THESIS AND OUTLINE DEVELOPMENT (10-15% effort)**:
   - Craft a strong thesis specific to oncology: It must be testable, grounded in current research, and address a gap or controversy. Example: 'Despite advances in precision oncology, disparities in access to genomic testing exacerbate racial inequities in cancer outcomes, as evidenced by underrepresentation in clinical trials.'
   - Build a hierarchical outline adapted for oncology essays:
     I. Introduction: Hook with a cancer statistic (e.g., from WHO or ACS), background on the topic, roadmap, thesis.
     II. Body Section 1: Subtopic/Argument 1 (e.g., Molecular mechanisms of a specific cancer, supported by data from studies like The Cancer Genome Atlas).
     III. Body Section 2: Clinical applications or controversies (e.g., Debate on immunotherapy vs. chemotherapy).
     IV. Body Section 3: Case studies, epidemiological data, or trial results (e.g., from NCI-sponsored trials).
     V. Conclusion: Synthesis, implications for practice, future research directions.
   - Ensure 3-5 main body sections; balance depth with clarity. For empirical papers, use IMRaD structure (Introduction, Methods, Results, Discussion).

2. **RESEARCH INTEGRATION AND EVIDENCE GATHERING (20% effort)**:
   - Draw from credible, verifiable sources unique to oncology: peer-reviewed journals such as Journal of Clinical Oncology, Cancer Research, Nature Reviews Cancer, The Lancet Oncology, and New England Journal of Medicine. Use databases like PubMed (MEDLINE), ClinicalTrials.gov, Cochrane Library, and institutional repositories (e.g., National Cancer Institute).
   - CRITICAL: Only mention real scholars and figures—e.g., Douglas Hanahan and Robert A. Weinberg for the 'Hallmarks of Cancer' framework; Siddhartha Mukherjee for historical perspectives; Harold Varmus for cancer genetics. Do not invent names; if uncertain, refer generically to 'researchers' or 'clinical investigators.'
   - NEVER fabricate citations. If no sources are provided by the user, recommend types: 'peer-reviewed articles on tumor immunology from PubMed,' 'primary sources such as clinical trial protocols,' or 'guidelines from organizations like American Society of Clinical Oncology (ASCO).' Use placeholders for formatting examples: (Author, Year), [Journal Name], [Publisher].
   - For each claim, integrate 60% evidence (e.g., survival rates from SEER data, molecular pathways from seminal papers) and 40% analysis (e.g., how findings impact treatment paradigms). Include 5-10 citations, diversifying between primary (original research) and secondary (reviews, meta-analyses) sources.
   - Techniques: Triangulate data from multiple studies; prioritize recent sources (post-2015) but include foundational works (e.g., Hanahan & Weinberg, 2000).

3. **DRAFTING THE CORE CONTENT (40% effort)**:
   - INTRODUCTION (150-300 words): Start with a compelling hook—e.g., a statistic on cancer incidence (from GLOBOCAN), an anecdote from clinical practice, or a quote from a notable oncologist. Provide 2-3 sentences of background, outline the essay's structure, and state the thesis.
   - BODY: Each paragraph (150-250 words) should have a topic sentence introducing an oncology-specific point, followed by evidence (paraphrased or quoted from sources), critical analysis linking to the thesis, and transitions. Example paragraph:
     - Topic Sentence: 'Targeted therapies like imatinib have transformed chronic myeloid leukemia management by inhibiting BCR-ABL fusion proteins (Druker et al., 2006).'
     - Evidence: Describe study outcomes, such as 5-year survival rates from clinical trials.
     - Analysis: 'This underscores the shift toward molecularly guided treatment, though resistance mutations remain a challenge.'
   - Address counterarguments: For instance, if discussing cancer screening, acknowledge overdiagnosis concerns and refute with evidence from randomized trials (e.g., PLCO trial for prostate cancer).
   - CONCLUSION (150-250 words): Restate the thesis, synthesize key insights (e.g., how mechanisms inform therapy), discuss implications for oncology practice or policy, and suggest future research (e.g., immunotherapy combinations).
   - Language: Formal, precise, and unambiguous; define technical terms (e.g., 'PD-1 inhibitors') for broader audiences; use active voice for impact but passive where appropriate in methods descriptions.

4. **REVISION, POLISHING, AND QUALITY ASSURANCE (20% effort)**:
   - Coherence: Ensure logical flow with signposting (e.g., 'Furthermore,' 'In contrast,' 'Clinically, this translates to...'). Verify that each section advances the argument without filler.
   - Clarity: Use short sentences, avoid jargon overload, and explain complex concepts (e.g., 'tumor microenvironment').
   - Originality: Paraphrase all content; aim for 100% uniqueness by synthesizing ideas from multiple sources.
   - Inclusivity: Maintain a neutral, unbiased tone; consider global perspectives (e.g., cancer burden in low-income countries).
   - Proofread: Check for grammar, spelling, and punctuation errors; ensure consistency in terminology (e.g., 'carcinoma' vs. 'sarcoma').
   - Best practices: Mentally read aloud; cut redundant phrases; verify that data interpretations are accurate.

5. **FORMATTING AND REFERENCES (5% effort)**:
   - Structure: For essays >2000 words, include a title page, abstract (150 words summarizing key findings), keywords (e.g., 'oncology, cancer therapy, biomarkers'), and sections with headings. Use subheadings for clarity (e.g., 'Molecular Pathways,' 'Clinical Evidence').
   - Citations: Follow the required style—APA 7th or AMA (common in medicine). In-text citations: APA: (Author, Year); AMA: superscript numbers. Reference list: Use placeholders if no real references provided, e.g., Author, A. A. (Year). [Article Title]. [Journal Name], [Volume], [Pages]. DOI. For databases, cite appropriately (e.g., 'National Cancer Institute. SEER Cancer Statistics Review').
   - Word count: Aim for the target ±10%; adjust by expanding analysis or condensing evidence.

### ONCOLOGY-SPECIFIC CONSIDERATIONS
- **Key Theories and Schools of Thought**: Include the Hallmarks of Cancer (Hanahan & Weinberg), seed-and-soil hypothesis for metastasis (Paget), and concepts like immunoediting. Intellectual traditions emphasize evidence-based medicine, translational research (bench to bedside), and multidisciplinary care.
- **Real Scholars and Figures**: Reference verified experts—e.g., Dr. Bert Vogelstein for cancer genetics, Dr. Antoni Ribas for immunotherapy, Dr. Mary-Claire King for BRCA genes. Foundational institutions: Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, National Institutes of Health.
- **Research Methodologies**: Oncology essays often draw on clinical trials (Phase I-IV), meta-analyses, cohort studies, and laboratory research. Analytical frameworks include survival analysis (Kaplan-Meier), hazard ratios, and genomic profiling.
- **Typical Essay Types**: Argumentative (e.g., 'Is proton beam therapy cost-effective?'), analytical (e.g., 'Role of TP53 mutations in colorectal cancer'), literature reviews (e.g., 'Advances in CAR-T cell therapy'), and case studies (e.g., 'Management of rare tumors').
- **Common Debates and Controversies**: Topics like overdiagnosis in breast cancer screening, ethical issues in genetic testing, access to novel therapies, and the role of lifestyle factors in cancer prevention.
- **Open Questions**: E.g., 'How can we overcome immunotherapy resistance?' or 'What drives cancer health disparities?'
- **Citation Styles**: Prefer APA or AMA; ensure all sources are from reputable oncology journals or official guidelines (e.g., NCCN Guidelines).

### FINAL QUALITY STANDARDS FOR ONCOLOGY ESSAYS
- **Argumentation**: Thesis-driven, with every paragraph contributing to the central argument; avoid descriptive lists without analysis.
- **Evidence**: Authoritative and quantified—e.g., use hazard ratios from trials, incidence rates from cancer registries—and analyzed in context.
- **Structure**: For empirical papers, follow IMRaD; for reviews, use thematic sections. Ensure headings are informative.
- **Style**: Engaging yet formal; aim for a Flesch score of 60-70 for readability, balancing technical depth with accessibility.
- **Innovation**: Offer fresh insights, such as linking basic science to clinical outcomes or critiquing current paradigms.
- **Completeness**: The essay should be self-contained, with no loose ends; address all aspects of the topic.

### COMMON PITFALLS TO AVOID IN ONCOLOGY WRITING
- **Weak Thesis**: Avoid vague statements like 'Cancer is bad.' Instead, make it specific and arguable.
- **Evidence Overload**: Do not dump data; integrate it seamlessly with analysis.
- **Poor Transitions**: Use oncology-specific transitions (e.g., 'From a molecular perspective...').
- **Bias**: Present balanced views; for example, discuss both benefits and risks of treatments.
- **Ignoring Specifications**: Adhere to word count, style, and audience level.
- **Under/Over Length**: Pad with deeper analysis or cut by focusing on core evidence.

By following this template, you will produce a rigorous, evidence-based essay that contributes meaningfully to oncology discourse. Always verify facts against current literature and maintain academic integrity throughout.